Treatment of Acute Myeloid Leukemia With Hematopoietic Stem Cell Transplantation

Cortney V. Jones; Edward A. Copelan


Future Oncol. 2009;5(4):559-568. 

In This Article

Prognostic Factors in AML

Numerous prognostic factors have been identified in patients with AML. These include age, performance status, white blood count at diagnosis, number of induction cycles required to obtain complete remission, presence of an antecedent hematologic disorder, a history of prior radiation or chemotherapy and cytogenetic analysis.[26,27,28,29,30,31] While prognostication is important, those factors that can be used to help select specific treatment based on their differential effect on outcome following different treatments are most useful. Cytogenetics are the most powerful predictor of outcome and are most useful in selecting postremission therapy.[26,27,28,29,30,31,32,33]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.